MARKET EYE-India's Cipla surges to record high on earnings

Tue Nov 6, 2012 10:23am IST

Related Topics

Stocks

   

* Shares in Cipla gains as much as 4.06 percent to a
record high after the drug maker reported a bigger-than-expected
62 percent surge in July-September net profit. 
* Despite the surge in share prices, Citigroup says on Tuesday
it remains cautious, saying the earnings surprise were mainly
driven by the generic version of anti-depressant drug Lexapro,
whose exclusivity would tail off in the second half of the
fiscal year.
* Cipla had earlier given a revenue guidance of up to 12 percent
 for the current fiscal year, but Citigroup says the company
management has now revised its topline growth to 15 percent or
above in FY13.     
* Citigroup adds positives such as better product mix and upside
from a weaker rupee appeared factored into estimates
and valuations. 
* The bank raised its target price to 390 rupees from 360
rupees, but retained its 'neutral' rating.
* Cipla shares advanced 2.8 percent to 390.90 rupees as of 0437
GMT

 (manoj.dharra@thomsonreuters.com)
FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Banking Sector

REUTERS SHOWCASE

Regulatory Troubles

Regulatory Troubles

U.S. regulator alleges Dr Reddy's breached packaging rules  Full Article 

Defence Sector

Defence Sector

Indian firms tool up for defence orders on Modi's 'buy India' pledge  Full Article 

Factory Activity

Factory Activity

Economy fears deepen as August HSBC flash PMI at three-month low  Full Article 

Fed Minutes

Fed Minutes

Fed notes labor market progress, but not convinced yet - minutes  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage